Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Hans J M, Smit"'
1
Akademický článek
Improving shared decision making for lung cancer treatment by developing and validating an open-source web based patient decision aid for stage I–II non-small cell lung cancer
Autor: Iva Halilaj, Anshu Ankolekar, Anouk Lenaers, Avishek Chatterjee, Cary J. G. Oberije, Lisanne Eppings, Hans J. M. Smit, Lizza E. L. Hendriks, Arthur Jochems, Relinde I. Y. Lieverse, Janita E. van Timmeren, Anke Wind, Philippe Lambin
Publikováno v: Frontiers in Digital Health, Vol 5 (2024)
The aim of this study was to develop and evaluate a proof-of-concept open-source individualized Patient Decision Aid (iPDA) with a group of patients, physicians, and computer scientists. The iPDA was developed based on the International Patient Decis
Externí odkaz: https://doaj.org/article/e12bdf591cc24ee2aa47f5ffbb7db295
Zobrazit plný text záznamu
2
Akademický článek
Birt-Hogg-Dubé syndrome in apparent primary spontaneous pneumothorax patients; results and recommendations for clinical practice
Autor: Jincey D. Sriram, Irma van de Beek, Paul C. Johannesma, Michiel H. van Werkum, Tijmen J. W. T. van der Wel, Elise M. Wessels, Hans J. J. P. Gille, Arjan C. Houweling, Pieter E. Postmus, Hans J. M. Smit
Publikováno v: BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Birt-Hogg-Dubé syndrome (BHD) is an inherited disease caused by pathogenic variants in the FLCN gene. One of the characteristics is the increased risk for spontaneous pneumothorax, likely due to the presence of pulmonary cysts ma
Externí odkaz: https://doaj.org/article/f65c31c8c14841f3b507b58dca520cd2
Zobrazit plný text záznamu
3
Akademický článek
Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer
Autor: Jinming Yu, Andrea Ardizzoni, Delvys Rodriguez-Abreu, Sergio Azevedo, Belen Rubio-Viqueira, Jorge Alatorre-Alexander, Hans J M Smit, Konstantinos Syrigos, Jonathan Tolson, Thomas Newsom-Davis, Elen Höglander, Monika Kaul, Youyou Hu, Hans Kristian Vollan
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
In patients with previously treated advanced or metastatic non-small cell lung cancer (NSCLC), atezolizumab therapy improves survival with manageable safety. The open-label, single-arm phase III/IV TAIL study (NCT03285763) evaluated atezolizumab mono
Externí odkaz: https://doaj.org/article/2ceefc7fcfd74dd3adcd680ddc725cbc
Zobrazit plný text záznamu
4
Akademický článek
Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC
Autor: Simon A. Keek, Esma Kayan, Avishek Chatterjee, José S. A. Belderbos, Gerben Bootsma, Ben van den Borne, Anne-Marie C. Dingemans, Hester A. Gietema, Harry J. M. Groen, Judith Herder, Cordula Pitz, John Praag, Dirk De Ruysscher, Janna Schoenmaekers, Hans J. M. Smit, Jos Stigt, Marcel Westenend, Haiyan Zeng, Henry C. Woodruff, Philippe Lambin, Lizza Hendriks
Publikováno v: Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Introduction: Despite radical intent therapy for patients with stage III non-small-cell lung cancer (NSCLC), cumulative incidence of brain metastases (BM) reaches 30%. Current risk stratification methods fail to accurately identify these patients. As
Externí odkaz: https://doaj.org/article/9a92cc6300fc4c7c9959e69e2b3229ec
Zobrazit plný text záznamu
5
Akademický článek
Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer
Autor: Jinming Yu, Andrés Cardona, Andrea Ardizzoni, Delvys Rodriguez-Abreu, Sergio Azevedo, Belen Rubio-Viqueira, Jorge Alatorre-Alexander, Hans J M Smit, Konstantinos Syrigos, Kerstin Trunzer, Hina Patel, Jonathan Tolson, Pablo D Perez-Moreno
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Atezolizumab treatment improves survival, with manageable safety, in patients with previously treated advanced/metastatic non-small cell lung cancer. The global phase III/IV study TAIL (NCT03285763) was conducted to evaluate the safety and
Externí odkaz: https://doaj.org/article/ff460346035746668e4d5b72630465b6
Zobrazit plný text záznamu
6
Akademický článek
Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial
Autor: Anita J. W. M. Brouns, Lizza E. L. Hendriks, Vincent van der Noort, Ben E. E. M van de Borne, Franz M. N. H. Schramel, Harry J. M. Groen, Bonne Biesma, Hans J. M. Smit, Anne-Marie C. Dingemans
Publikováno v: Frontiers in Oncology, Vol 10 (2020)
Introduction: Approximately 80% of non-small cell lung cancer (NSCLC) patients with bone metastases have cancer induced bone pain (CIBP).Methods: The NVALT-9 was an open-label, single arm, phase II, multicenter study. Main inclusion criterion: bone m
Externí odkaz: https://doaj.org/article/db1dcfc06ffd45d3bb132904966c9e1b
Zobrazit plný text záznamu
8
Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer
Autor: Andrea Ardizzoni, Sergio Azevedo, Belen Rubio-Viqueira, Delvys Rodriguez-Abreu, Jorge Alatorre-Alexander, Hans J M Smit, Jinming Yu, Konstantinos Syrigos, Elen Höglander, Monika Kaul, Jonathan Tolson, Youyou Hu, Hans Kristian Vollan, Thomas Newsom-Davis
Publikováno v: Journal for ImmunoTherapy of Cancer. 10:e005581
In patients with previously treated advanced or metastatic non-small cell lung cancer (NSCLC), atezolizumab therapy improves survival with manageable safety. The open-label, single-arm phase III/IV TAIL study (NCT03285763) evaluated atezolizumab mono
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7cbe6ca5e251b4996409bcdfada2d7b
https://doi.org/10.1136/jitc-2022-005581
Zobrazit plný text záznamu
9
Flexible bronchoscopy in supine or sitting position: a randomized prospective analysis of safety and patient comfort
Autor: Erik F. G. Kapteijns, Sylvia Lahey, Janet P. van Zwam, Hans J. M. Smit
Publikováno v: Journal of bronchologyinterventional pulmonology. 17(1)
Background Flexible bronchoscopy is performed under many different conditions (sitting/supine position, with or without oxygen prophylaxis) in different hospitals according to local traditions. Objectives The study was to investigate the effect of di
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acd6e4989605bf0f5d680c81fb6cbb02
https://pubmed.ncbi.nlm.nih.gov/23168656
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje